南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (9): 2173-2184.doi: 10.12122/j.issn.1673-4254.2026.09.16
• • 上一篇
李百超1(
), 王炳哲1, 梅向辉1, 田野1, 韩亮1, 张九娜2(
)
收稿日期:2025-12-25
出版日期:2026-09-20
发布日期:2026-09-30
通讯作者:
张九娜
E-mail:1832492339@qq.com;shitouli1020@163.com
作者简介:李百超,在读硕士研究生,E-mail: 1832492339@qq.com
基金资助:
Baichao LI1(
), Bingzhe WANG1, Xianghui MEI1, Ye TIAN1, Liang HAN1, Jiuna ZHANG2(
)
Received:2025-12-25
Online:2026-09-20
Published:2026-09-30
Contact:
Jiuna ZHANG
E-mail:1832492339@qq.com;shitouli1020@163.com
摘要:
目的 探讨磷脂酰肌醇聚糖锚定生物合成T类(PIGT)在结直肠癌进展中的生物学功能及相关分子机制。 方法 利用数据库GEPIA、UALCAN、TNMplot分析PIGT在结直肠癌组织与配对正常组织中的表达差异;通过qPCR及Western blotting在结直肠癌细胞系(HCT116,HCT8)与正常结直肠黏膜细胞系(NCM460)中验证其表达水平。利用Kaplan-Meier plotter数据库,探究PIGT表达与结直肠癌患者10年无复发生存期(RFS)的关联。采用质粒转染技术在HCT116、 HCT8细胞中敲低PIGT,结合集落形成实验、软琼脂克隆实验、Transwell迁移及侵袭实验、伤口愈合实验及体外血管形成实验,评估PIGT对结直肠癌细胞增殖、克隆形成、迁移、侵袭及血管生成能力的影响;基于敲低组与对照组的转录组测序及通路富集结果,选定NF-κB通路进行验证,并通过Western blotting检测敲低PIGT后NF-κB通路关键蛋白(P-P65、P65)及上皮-间质转化(EMT)相关标志物(E-cadherin、N-cadherin、Vimentin、MMP9、VEGF-C)的表达变化,通过脂多糖恢复实验进一步分析其通路调控关系;构建裸鼠皮下荷瘤模型,将PIGT敲低组与对照组HCT116细胞分别接种于裸鼠背部皮下,取瘤后测量肿瘤重量,观察PIGT敲低对体内肿瘤生长的影响。 结果 公共数据库(TNMplot、UALCAN、GEPIA)分析及细胞水平验证显示,PIGT在结直肠癌组织及细胞系中均高表达(P<0.05)。Kaplan-Meier plotter数据库生存分析显示,中晚期(Ⅱ~Ⅳ期)结直肠癌患者中,PIGT高表达者的无复发生存期缩短(P<0.05)。功能实验证实,敲低PIGT可抑制结直肠癌细胞的增殖、克隆形成、迁移、侵袭及体外血管生成能力(P<0.05);同时上调上皮标志物E-cadherin表达,下调间质标志物N-cadherin、Vimentin、MMP9、VEGF-C的表达,从而逆转上皮间质转化进程(P<0.05)。在机制层面,转录组测序及通路富集分析显示NF-κB信号通路在PIGT敲低后下调;Western blotting验证显示,PIGT敲低组NF-κB通路关键蛋白P-P65的磷酸化水平降低(P<0.05),脂多糖恢复实验可逆转 PIGT 敲低所致的 NF-κB 通路抑制及 EMT 相关蛋白异常表达。裸鼠体内荷瘤实验结果显示,与对照组相比,PIGT敲低组裸鼠皮下肿瘤的质量降低(P<0.05)。 结论 PIGT在结直肠癌中异常高表达,可能通过影响NF-κB信号通路促进结直肠癌细胞增殖、迁移、侵袭及EMT进程,有望成为结直肠癌潜在的预后生物标志物及靶向治疗靶点。
李百超, 王炳哲, 梅向辉, 田野, 韩亮, 张九娜. 磷脂酰肌醇聚糖锚定生物合成T类经由 NF-κB 通路调控上皮间质转化并促进结直肠癌恶性进展[J]. 南方医科大学学报, 2026, 46(9): 2173-2184.
Baichao LI, Bingzhe WANG, Xianghui MEI, Ye TIAN, Liang HAN, Jiuna ZHANG. Phosphatidylinositol glycan anchor biosynthesis class T promotes malignant phenotype of colon cancer through the NF-κB signaling pathway[J]. Journal of Southern Medical University, 2026, 46(9): 2173-2184.
图1 结直肠癌组织中PIGT表达升高
Fig.1 Elevated expression of PIGT in colorectal cancer tissues. A: Pan cancer analysis based on the TNMplot database show that PIGT mRNA levels are significantly upregulated in multiple malignancies, including colorectal cancer (CRC), compared with corresponding normal tissues. B: Validation using the UALCAN database demonstrates that PIGT mRNA levels in primary tumor tissues are significantly higher than those in adjacent normal tissues in both colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ). C: Analysis using the GEPIA database shows that PIGT mRNA expression is significantly increased in COAD and READ samples compared with normal controls. *P<0.05.
图3 PIGT在结直肠癌细胞系中表达上调
Fig.3 PIGT expression is upregulated in colorectal cancer cell lines. A: qPCR analysis of PIGT mRNA levels in two colorectal cancer cell lines (HCT116 and HCT8) and the normal colorectal mucosal cell line NCM460. B: Western blotting analysis of PIGT protein expression in the same cell lines. All data represent the Mean±SD from 3 independent experiments. *P<0.05 vs NCM460.
图5 PIGT敲低抑制结直肠癌细胞增殖能力
Fig.5 Knockdown of PIGT inhibits proliferation of colorectal cancer cells. A: Knockdown of PIGT significantly reduces the number and size of colonies compared with the sh-NC control group. B: PIGT knockdown markedly decreases the number of colony spheres formed in soft agar. ***P<0.001 (n=3).
图6 PIGT敲低抑制结直肠癌细胞的迁移与侵袭能力
Fig.6 Knockdown of PIGT attenuates migration and invasion of CRC cells. A: Wound healing assay in HCT116 and HCT8 cells transfected with sh NC or sh PIGT. Knockdown of PIGT significantly delays wound closure compared with the control group. B: Transwell migration assay. PIGT knockdown markedly reduces the number of cells migrating through the polycarbonate membrane. C: Matrigel invasion assay. PIGT knockdown similarly impairs the ability of cells to penetrate the Matrigel barrier. ***P<0.001 (n=3).
图8 PIGT敲低可下调效应分子表达,从而逆转CRC细胞的EMT
Fig.8 PIGT knockdown reverses EMT by downregulating its effector molecules in CRC cells. A: Western blotting of N cadherin, E cadherin, Vimentin, MMP9, and VEGF-C protein levels in HCT116 cells after PIGT knockdown. GAPDH was used as a loading control. B: Western blotting and quantification of the same proteins in HCT8 cells. ***P<0.001 (n= 3).
图9 功能富集分析揭示了与PIGT相关的关键通路与生物学过程
Fig.9 Functional enrichment analysis reveals key pathways and biological processes associated with PIGT. A: Number of differentially expressed genes upon PIGT knockdown. B: GO enrichment analysis of the differentially expressed genes. C: KEGG pathway enrichment analysis of the differentially expressed genes.
图10 PIGT调控NF-κB信号通路的蛋白质水平验证
Fig.10 Protein level validation of PIGT-mediated regulation of NF‑κB signaling. A: Western blotting of P65 and phosphorylated P65 (P-P65) in HCT116 cells after PIGT knockdown. B: Western blotting analysis of P65 and P-P65 in HCT8 cells after PIGT knockdown. ***P<0.001 (n=3).
图11 脂多糖逆转 PIGT 敲低对结直肠癌细胞 NF-κB 通路及 EMT 的抑制作用
Fig.11 LPS reverses PIGT knockdown-induced inhibition of NF-κB pathway and EMT in colorectal cancer cells. A: Western blotting of P P65, E cadherin, N cadherin, vimentin, MMP9, and VEGF-C in HCT116 cells in sh NC, sh PIGT, and sh PIGT+LPS (1 μg/mL LPS, 24 h) groups. B: Western blotting analysis of the same proteins in HCT8 cells. *P<0.05, **P<0.01, ***P<0.001 (n=3).
图 12 敲低 PIGT 抑制裸鼠皮下结直肠癌肿瘤生长
Fig.12 Knockdown of PIGT inhibits growth of colorectal cancer xenografts in nude mice. A: Representative images of xenograft tumors derived from HCT116 cells transfected with sh NC or sh PIGT. B: Western blotting of PIGT protein expression in tumor tissues, confirming efficient PIGT knockdown in vivo. **P<0.01, ***P<0.001.
| [1] | Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-63. doi:10.3322/caac.21834 |
| [2] | Zhou YY, Song K, Chen YQ, et al. Burden of six major types of digestive system cancers globally and in China[J]. Chin Med J, 2024, 137(16): 1957-64. doi:10.1097/cm9.0000000000003225 |
| [3] | Weng WH, Feng JL, Qin HL, et al. Molecular therapy of colorectal cancer: Progress and future directions[J]. Int J Cancer, 2015, 136(3): 493-502. doi:10.1002/ijc.28722 |
| [4] | Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics[J]. Trends Pharmacol Sci, 2023, 44(4): 222-36. doi:10.1016/j.tips.2023.01.003 |
| [5] | Li WH, Zhou SZ. Identification of a novel splicing variant in the phosphatidylinositol glycan class S (PIGS) gene that is associated with early onset epilepsy, severe developmental delay, and ventricular septal defect: a case report[J]. Transl Pediatr, 2023, 12(3): 514-20. doi:10.21037/tp-22-317 |
| [6] | Wu TH, Yin F, Guang SQ, et al. The Glycosylphosphatidylinositol biosynthesis pathway in human diseases[J]. Orphanet J Rare Dis, 2020, 15(1): 129. doi:10.1186/s13023-020-01401-z |
| [7] | Wu GJ, Guo ZM, Chatterjee A, et al. Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer[J]. Cancer Res, 2006, 66(20): 9829-36. doi:10.1158/0008-5472.can-06-0506 |
| [8] | Zhao P, Nairn AV, Hester S, et al. Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma[J]. J Biol Chem, 2012, 287(30): 25230-40. doi:10.1074/jbc.m112.339465 |
| [9] | Tan MY, Pan Q, Yu C, et al. PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking[J]. J Transl Med, 2024, 22: 5. doi:10.1186/s12967-023-04805-0 |
| [10] | Amit M, Nara S, Francis D, et al. Post-translational regulation of radioactive iodine therapy response in papillary thyroid carcinoma [J]. J Natl Cancer Inst, 2017, 109(12): 1-10. doi:10.1093/jnci/djx092 |
| [11] | Cao JZ, Wang PH, Chen JM, et al. PIGU overexpression adds value to TNM staging in the prognostic stratification of patients with hepatocellular carcinoma[J]. Hum Pathol, 2019, 83: 90-9. doi:10.1016/j.humpath.2018.08.013 |
| [12] | Wei X, Yang WJ, Zhang F, et al. PIGU promotes hepatocellular carcinoma progression through activating NF‑κB pathway and increasing immune escape[J]. Life Sci, 2020, 260: 118476. doi:10.1016/j.lfs.2020.118476 |
| [13] | Soleimani A, Rahmani F, Ferns GA, et al. Role of the NF‑κB signaling pathway in the pathogenesis of colorectal cancer[J]. Gene, 2020, 726: 144132. doi:10.1016/j.gene.2019.144132 |
| [14] | Wang YZ. Comment on "Regulation of nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?" [Cancer Lett. 509 (2021 May 2) 63-80[J]. Cancer Lett, 2021, 516: 99-100. doi:10.1016/j.canlet.2021.05.028 |
| [15] | Jodo A, Shibazaki A, Onuma A, et al. Pdlim7 synergizes with pdlim2 and p62/Sqstm1 to inhibit inflammatory signaling by promoting degradation of the p65 subunit of NF-κB[J]. Front Immunol, 2020, 11: 1559. doi:10.3389/fimmu.2020.01559 |
| [16] | Tang Q, Chen JH, Di ZY, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer[J]. J Exp Clin Cancer Res, 2020, 39(1): 232. doi:10.1186/s13046-020-01690-z |
| [17] | Xu D, Li MR, Ran LY, et al. C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway[J]. Clin Transl Oncol, 2023, 25(2): 440-6. doi:10.1007/s12094-022-02956-y |
| [18] | Long XL, Hu YK, Duan SY, et al. MRGBP promotes colorectal cancer metastasis via DKK1/Wnt/β‑catenin and NF-kB/p65 pathways mediated EMT[J]. Exp Cell Res, 2022, 421(1): 113375. doi:10.1016/j.yexcr.2022.113375 |
| [19] | Wang Y, Liu F, Chen L, et al. Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF‑κB/NLRP3 inflammasome pathway[J]. Front Immunol, 2022, 13: 867516. doi:10.3389/fimmu.2022.867516 |
| [20] | Mirzaei S, Saghari S, Bassiri F, et al. NF-κB as a regulator of cancer metastasis and therapy response: a focus on epithelial-mesenchymal transition[J]. J Cell Physiol, 2022, 237(7): 2770-95. doi:10.1002/jcp.30759 |
| [21] | Bakir B, Chiarella AM, Pitarresi JR, et al. EMT, MET, plasticity, and tumor metastasis[J]. Trends Cell Biol, 2020, 30(10): 764-76. doi:10.1016/j.tcb.2020.07.003 |
| [22] | Manfioletti G, Fedele M. Epithelial-mesenchymal transition (EMT) 2021[J]. Int J Mol Sci, 2022, 23(10): 5848. doi:10.3390/ijms23105848 |
| [23] | Debnath P, Huirem RS, Dutta P, et al. Epithelial-mesenchymal transition and its transcription factors[J]. Biosci Rep, 2022, 42: BSR20211754. doi:10.1042/bsr20211754 |
| [24] | Perkins ND. The diverse and complex roles of NF‑κB subunits in cancer [J]. Nat Rev Cancer, 2012, 12(2): 121-32. doi:10.1038/nrc3204 |
| [25] | Yang SC, Liu Y, Li MY, et al. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer[J]. Mol Cancer, 2017, 16(1): 124. doi:10.1186/s12943-017-0700-1 |
| [26] | Karin M, Cao Y, Greten FR, et al. NF‑κB in cancer: from innocent bystander to major culprit [J]. Nat Rev Cancer, 2002, 2(4): 301-10. doi:10.1038/nrc780 |
| [27] | Fang LL, Che Y, Zhang CQ, et al. PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR/Akt/NF-κB/IL8 pathway[J]. Cell Death Discov, 2021, 7: 32. doi:10.1038/s41420-021-00410-6 |
| [28] | Fu YJ, Xu B, Huang SW, et al. Baicalin prevents LPS-induced activation of TLR4/NF‑κB p65 pathway and inflammation in mice via inhibiting the expression of CD14 [J]. Acta Pharmacol Sin, 2021, 42(1): 88-96. doi:10.1038/s41401-020-0411-9 |
| [29] | Li QY, Lai QH, He CC, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β‑catenin signalling pathway and EMT in colorectal cancer[J]. J Exp Clin Cancer Res, 2019, 38(1): 334. doi:10.1186/s13046-019-1330-9 |
| [1] | 徐展发, 陈贞月, 谢丽萍, 李馨怡, 秦耿耿, 郜洁. 减味寿胎丸通过抑制Exo-miR-410-3p摄取促进滋养细胞上皮间质转化、迁移及侵袭减少胚胎流产[J]. 南方医科大学学报, 2026, 46(9): 2006-2022. |
| [2] | 徐璐, 潘缘瑾, 汪雨辰, 陈振宇, 蒋伟, 於江泉, 郑瑞强. 血必净注射液通过上调磷脂转运蛋白调控巨噬细胞JNK/c-JUN通路改善脓毒症相关急性呼吸窘迫综合征[J]. 南方医科大学学报, 2026, 46(9): 2035-2045. |
| [3] | 黄丽萍, 邵玉, 周婉冰, 何景萍. 肝细胞癌源性乳酸介导组蛋白H3K18乳酸化修饰调控S100A2转录促进肝癌细胞的增殖、迁移、侵袭及上皮间质转化[J]. 南方医科大学学报, 2026, 46(9): 2056-2068. |
| [4] | 于梦洁, 赵安博, 郝艺璇, 王奕人, 刘月娴, 叶红伟, 高琴. 敲除脂质运载蛋白2通过抑制NF-κB通路改善脓毒症急性肺损伤小鼠血管内皮屏障功能[J]. 南方医科大学学报, 2026, 46(8): 1779-1789. |
| [5] | 高建红, 史册, 李蔚然, 尚祥, 王飞, 杨琪琪, 李飞. 电针改善血管性痴呆大鼠认知障碍并抑制TLR4/MyD88/NF-κB通路介导的星形胶质细胞活化[J]. 南方医科大学学报, 2026, 46(8): 1814-1822. |
| [6] | 李春宁, 杨琪琪, 张振丰, 鲍亮, 姜天鑫, 张玉, 李飞. 电针通过调控TLR4/MyD88/NF-κB信号通路减轻膝关节骨关节炎大鼠膝关节软骨凋亡[J]. 南方医科大学学报, 2026, 46(8): 1886-1895. |
| [7] | 石科林, 齐霄川, 徐世祥, 高缘圆, 房明哲, 胡俊诚, 王春景, 刘长青, 郭俣. CHIR99021通过抑制GSK-3β/NF-κB信号通路减轻帕金森病小鼠的神经炎症[J]. 南方医科大学学报, 2026, 46(7): 1593-1600. |
| [8] | 孙宇航, 卢兴珍, 张馨月, 郭建鹏, 金鑫. 熊胆粉通过调控NF-κB和Nrf-2/HO-1信号通路减轻脂多糖诱导的小鼠急性肺损伤[J]. 南方医科大学学报, 2026, 46(7): 1622-1633. |
| [9] | 谭彬, 翁诺舟, 曾文涛, 古家宇, 翁炼基, 温慧琳, 肖浩成, 郑克鸿. 乙醇通过激活TGF-β/Smad/P21信号轴促进结直肠癌奥沙利铂的耐药性[J]. 南方医科大学学报, 2026, 46(5): 1066-1074. |
| [10] | 韩亮, 李百超, 王炳哲, 张志伟, 张九娜. 吐根酚碱通过Ras信号通路抑制结直肠癌的恶性生物学行为[J]. 南方医科大学学报, 2026, 46(5): 1121-1130. |
| [11] | 张浚琪, 白净, 任行, 叶学帅, 檀梦天, 杨勇, 李磊, 付泽娴. 菌群移植通过调节TLR4/MyD88/NF-κB信号通路抑制小鼠结肠肿瘤生长[J]. 南方医科大学学报, 2026, 46(5): 1139-1148. |
| [12] | 丁宁, 彭天书, 莫黎, 胡响当, 杨宗亮, 肖佑, 付肖冰, 赵建政, 李磊磊, 张英杰. 多组学整合揭示结直肠癌中的免疫-代谢异质性:针对ANGPTL4/FABP4/RBP7的预后模型及治疗策略[J]. 南方医科大学学报, 2026, 46(5): 977-993. |
| [13] | 刘安澜, 过伟峰, 李建香, 张天鸽, 徐丹. KLF10通过下调NF-κB/NLRP3通路改善大鼠焦虑性抑郁行为及神经炎症[J]. 南方医科大学学报, 2026, 46(5): 994-1005. |
| [14] | 金成桓, 洪宗超, 段雪云, 范恒, 杨晶鑫, 秦佳美, 邹丽艳, 覃孟渊. 化结消瘤方中的熊果酸通过诱导铜死亡抑制结直肠癌细胞生长[J]. 南方医科大学学报, 2026, 46(4): 825-837. |
| [15] | 刘超群, 宁紫燕, 吴江华, 刘魏魏, 林创, 许嘉玮, 周蕊, 赵亮. 结直肠癌细胞分泌牙本质涎磷蛋白通过整合素αvβ3依赖途径诱导奥沙利铂耐药[J]. 南方医科大学学报, 2026, 46(3): 479-488. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||